Analysed SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) News Sources
Assessing Santen Pharmaceutical (TSE:4536) Valuation After Recent Share Price Strength
28-03-2026
yahoo.com
Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities
26-03-2026
yahoo.com
RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%
08-01-2026
yahoo.com
Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Bausch + Lomb, Santen Pharmaceutical, and Trefoil Therapeutics, Actively Shaping the Competitive Landscape
01-10-2025
yahoo.com
Does Santen Share Price Reflect Its True Value After Recent Global Pharma Optimism in 2025?
15-09-2025
yahoo.com
Santen and RemeGen sign licence deal for retinal disease injection
19-08-2025
pharmaceutical-technology.com
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries
19-08-2025
yahoo.com
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
07-08-2025
yahoo.com
What is the current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The current price of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is $11.3592.
SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is $0.0692.
SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) since the previous trading day is 0.6129%.
What is the most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The most recent average sentiment score for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)?
The most recent sentiment for SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS) is .
SEC-8K** Filing Available For SANTEN PHARMACEUTICAL-UN ADR (SNPHY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.